Literature DB >> 28346566

Gene- Gene Interaction between PPARG and APOE Gene on Late-Onset Alzheimer's Disease: A Case- Control Study in Chinese Han Population.

S Wang1, L Guan, D Luo, J Liu, H Lin, X Li, X Liu.   

Abstract

AIMS: The aim was to investigate the impact of PPARG and APOE gene single nucleotide polymorphisms (SNPs) and additional gene- gene interaction on late-onset Alzheimer's disease (LOAD) risk based on Chinese Han population.
METHODS: A total of 928 participants (466 males, 462 females), with a mean age of 81.3 ± 16.4 years old, were included in the study, including 460 LOAD patients and 468 normal controls participants. Logistic regression was performed to investigate association between SNP and LOAD risk and generalized multifactor dimensionality reduction (GMDR) was used to analysis the gene-gene interaction.
RESULTS: Logistic regression analysis showed that LOAD risk was significantly higher in carriers of G allele of the rs405509 polymorphism than those with AA (AG+ GG versus AA, adjusted OR (95%CI) =1.54(1.20-1.89), and higher in carriers of G allele of the rs1805192 polymorphism than those with CC (CG+ GG versus CC, adjusted OR (95%CI) =1.32(1.16-2.43). We also found that there was a potential gene-gene interaction between rs405509 and rs1805192. Participants with AG or GG of rs405509 and CG or GG of rs1805192 genotype have the highest AD risk, compared to participants with AA of rs405509 and CC of rs1805192 genotype, OR (95%CI) was 2.62(1.64 -3.58), after covariates adjustment.
CONCLUSIONS: G allele of the rs405509 of APOE and G allele of the rs1805192 of PPAR G polymorphism were associated with increased LOAD risk, and participants with AG or GG of rs405509 and CG or GG of rs1805192 genotype have the highest AD risk.

Entities:  

Keywords:  APOE; Alzheimer’s disease; PPARG; interaction

Mesh:

Substances:

Year:  2017        PMID: 28346566     DOI: 10.1007/s12603-016-0794-y

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  29 in total

Review 1.  Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease.

Authors:  Evan Dorey; Nina Chang; Qing Yan Liu; Ze Yang; Wandong Zhang
Journal:  Neurosci Bull       Date:  2014-03-20       Impact factor: 5.203

Review 2.  Power and pitfalls of the genome-wide association study approach to identify genes for Alzheimer's disease.

Authors:  Richard Sherva; Lindsay A Farrer
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

3.  Nutritional Guidance Improves Nutrient Intake and Quality of Life, and May Prevent Falls in Aged Persons with Alzheimer Disease Living with a Spouse (NuAD Trial).

Authors:  M H Suominen; T M Puranen; S K Jyväkorpi; U Eloniemi-Sulkava; H Kautiainen; U Siljamäki-Ojansuu; K H Pitkalä
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

Review 4.  Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease).

Authors:  A D Roses; A M Saunders; Y Huang; J Strum; K H Weisgraber; R W Mahley
Journal:  Pharmacogenomics J       Date:  2006-06-13       Impact factor: 3.550

5.  Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.

Authors:  Magdalena Sastre; Ilse Dewachter; Steffen Rossner; Nenad Bogdanovic; Evan Rosen; Peter Borghgraef; Bernd O Evert; Lucia Dumitrescu-Ozimek; Dietmar R Thal; Gary Landreth; Jochen Walter; Thomas Klockgether; Fred van Leuven; Michael T Heneka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

6.  Lack of genetic associations between PPAR-γ gene rs1801282 polymorphism and Alzheimer's disease in general population: a meta-analysis.

Authors:  Yongfu Wu; Qingyun Wu; Hanbin Zhang; Chuyan Chen; Guangzhao Chen; Huiling Yang; Dongyun Qin; Hui Fu
Journal:  Gene       Date:  2015-03-11       Impact factor: 3.688

7.  Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.

Authors:  Seppo Helisalmi; Timo Tarvainen; Saila Vepsäläinen; Anne Mari Koivisto; Mikko Hiltunen; Hilkka Soininen
Journal:  Neurosci Lett       Date:  2008-06-17       Impact factor: 3.046

8.  Role of genes and environments for explaining Alzheimer disease.

Authors:  Margaret Gatz; Chandra A Reynolds; Laura Fratiglioni; Boo Johansson; James A Mortimer; Stig Berg; Amy Fiske; Nancy L Pedersen
Journal:  Arch Gen Psychiatry       Date:  2006-02

9.  Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia.

Authors:  Nobuto Shibata; Yumiko Motoi; Hiroyuki Tomiyama; Tohru Ohnuma; Bolati Kuerban; Katrin Tomson; Miwa Komatsu; Hiromi Shimazaki; Nobutaka Hattori; Heii Arai
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2013-05-18

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  7 in total

1.  Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.

Authors:  Anatoliy I Yashin; Fang Fang; Mikhail Kovtun; Deqing Wu; Matt Duan; Konstantin Arbeev; Igor Akushevich; Alexander Kulminski; Irina Culminskaya; Ilya Zhbannikov; Arseniy Yashkin; Eric Stallard; Svetlana Ukraintseva
Journal:  Exp Gerontol       Date:  2017-10-26       Impact factor: 4.032

2.  Association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimer's disease: A meta-analysis.

Authors:  Hanyan Xiao; Yifeng Gao; Lei Liu; Yan Li
Journal:  EXCLI J       Date:  2017-06-20       Impact factor: 4.068

3.  Pharmacological Targets and the Biological Mechanisms of Formononetin for Alzheimer's Disease: A Network Analysis.

Authors:  Hai Xiao; Xinyue Qin; Jinping Wan; Rong Li
Journal:  Med Sci Monit       Date:  2019-06-08

Review 4.  EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease.

Authors:  Vladimir Khavinson; Natalia Linkova; Ekaterina Kozhevnikova; Svetlana Trofimova
Journal:  Molecules       Date:  2020-12-31       Impact factor: 4.411

5.  Effects of the association between APOE rs405509 polymorphisms and gene-environment interactions on hand grip strength among middle-aged and elderly people in a rural population in southern China.

Authors:  Haoyu He; Huaxiang Lu; Shuzhen Liu; Jiansheng Cai; Xu Tang; Chunbao Mo; Xia Xu; Quanhui Chen; Min Xu; Chuntao Nong; Qiumei Liu; Junling Zhang; Jian Qin; Zhiyong Zhang
Journal:  J Orthop Surg Res       Date:  2021-06-11       Impact factor: 2.359

6.  Lithium alters expression of RNAs in a type-specific manner in differentiated human neuroblastoma neuronal cultures, including specific genes involved in Alzheimer's disease.

Authors:  Bryan Maloney; Yokesh Balaraman; Yunlong Liu; Nipun Chopra; Howard J Edenberg; John Kelsoe; John I Nurnberger; Debomoy K Lahiri
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379

7.  A Network Pharmacological Approach to Investigate the Mechanism of Action of Active Ingredients of Epimedii Herba and Their Potential Targets in Treatment of Alzheimer's Disease.

Authors:  Yajuan Li; Qin Yang; Yang Yu
Journal:  Med Sci Monit       Date:  2020-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.